Novo Nordisk
NVO
#22
Rank
NZ$700.55 B
Marketcap
$150.30
Share price
-17.83%
Change (1 day)
-8.57%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$31.92 Billion

According to Novo Nordisk's latest financial reports the company has NZ$31.92 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$24.95 B31.79%
2022-12-31$NZ$18.93 B20.08%
2021-12-31$NZ$15.76 B8.7%
2020-12-31$NZ$14.50 B13.15%
2019-12-31$NZ$12.82 B8.29%
2018-12-31$NZ$11.84 B4.71%
2017-12-31$NZ$11.30 B22.2%
2016-12-31$NZ$9.25 B-7.99%
2015-12-31$NZ$10.05 B19.73%
2014-12-31$NZ$8.39 B-12.42%
2013-12-31$NZ$9.59 B9.51%
2012-12-31$NZ$8.75 B4.78%
2011-12-31$NZ$8.35 B-2.25%
2010-12-31$NZ$8.55 B-9.78%
2009-12-31$NZ$9.47 B-11.4%
2008-12-31$NZ$10.69 B29.93%
2007-12-31$NZ$8.23 B8.57%
2006-12-31$NZ$7.58 B18.64%
2005-12-31$NZ$6.39 B-6.12%
2004-12-31$NZ$6.80 B3.45%
2003-12-31$NZ$6.58 B6.85%
2002-12-31$NZ$6.15 B-9.54%
2001-12-31$NZ$6.80 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$163.66 B 412.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.32 B-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.41 B-4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$138.36 B 333.42%๐Ÿ‡ซ๐Ÿ‡ท France